Eps 1: hepatocarcinoma patient journey

Aim: To better understand the hepatocellular carcinoma (HCC) patient journey, we conducted a patient survey across 13 countries.
Our results show that patients in Europe reported a higher perceived lack of information than those in The Americas and Asia-Pacific.
The paper reports the results of a recent global survey of patients living with HCC, and shows that, irrespective of their geographic location, patients with HCC have to confront the genuine fear and anxiety that accompanies the diagnosis of any serious illness.